vTv Therapeutics

The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
Yahoo/Benzinga
Merck
Pifeltro
FDA
Delstrigo
Novo Nordisk
oral semaglutide
Kodiak Sciences
MeiraGTx Holdings
IPOs
Exagen
IGM Biosciences
Arrowhead Pharmaceuticals
Lexicon Pharmaceuticals
Bluebird Bio
vTv Therapeutics
Flag link:
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
clinical trials
Takeda
Zinfandel Pharmaceuticals
pioglitazone
Alzheimer's disease
Boehringer Ingelheim
BI 409306
Merck
verubecestat
Celgene
MS
ozanimod
Incyte
ID01
melanoma
vTv Therapeutics
azeliragon
Roche
Tecentriq
Exelixis
colorectal cancer
JNJ
atabacestat
Sareptat Therapeutics
DMD
Exondys 51
Alkermes
ALKS-5461
clinical depression
Flag link:
vTv Therapeutics Announces Deal in Asia for its PDE4 Inhibitor
vTv Therapeutics Announces Deal in Asia for its PDE4 Inhibitor
CP Wire
vTv Therapeutics
COPD
PDE4 inhibitors
Flag link:
vTv Therapeutics Announces Deal in Asia for its PDE4 Inhibitor
vTv Therapeutics
Flag link:
vTv therapeutics Alzheimer's Drug Fails to Reach Primary Endpoints in Ph III study
vTv therapeutics Alzheimer's Drug Fails to Reach Primary Endpoints in Ph III study
CP Wire
vTv Therapeutics
azeliragon
Alzheimer's disease
Flag link:
vTv therapeutics Alzheimer's Drug Fails to Reach Primary Endpoints in Ph III study
vTv Therapeutics
azeliragon
Alzheimer's disease
Flag link:
Another Alzheimer's IPO
Another Alzheimer's IPO
Seeking Alpha
Alzheimer's disease
azeliragon
vTv Therapeutics
Flag link: